Compare Ovintiv Inc. (DE) (OVV) vs Stryker Corporation (SYK) Price & Performance

Ovintiv Inc. (DE)Trade

Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Ovintiv Inc. (DE) vs Stryker Corporation — how do they compare? Ovintiv Inc. (DE) trades at $63.84 (market cap $17.53B), while Stryker Corporation trades at $277.8 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 6.1× Ovintiv Inc. (DE)'s market cap, and Ovintiv Inc. (DE) pays the higher dividend (1.89%). Which is the better fit depends on your goals — on Pluang, investors hold Ovintiv Inc. (DE) for 1 Days and Stryker Corporation for 21 Days on average.

	OVV	SYK
Market Cap	$17.53B	$106.24B
Volume	3,002,714	2,982,001
Sector	Energy	Health
52-Week High	$66.97	$388.35
52-Week Low	$35.97	$269.75
Typical Hold Time	1 Days	21 Days
Enterprise Value	$21.86B	$117.70B
Dividend Yield	1.89%	1.27%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ovintiv Inc. (DE)

No Aura AI signal available yet.

Stryker Corporation

Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.

The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OVV

Ovintiv to release Q3 2026 results on Nov 3, with conference call on Nov 4PRNewsWire · 8 hours agoNeutral View details →

SYK

Stryker faces investigation after CEO reveals ongoing manufacturing issues, stock drops nearly 9%.PRNewsWire · 1 day agoBearish Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlookDanny Green · 3 days agoNeutral Stryker upgraded to 'Strong Buy' after price drop to $275, showing strong growth and solid returns potential.Seeking Alpha · 4 days agoBullish View details →

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.